Industries > Pharma > Pre-Filled Syringes: World Industry and Market Prospects 2014-2024

Pre-Filled Syringes: World Industry and Market Prospects 2014-2024

PUBLISHED: 11 November 2013
PAGES: 198
PRODUCT CODE:
SUBMARKET: Medical Devices

Clear
WOOCS 2.2.1
SKU: N/A Categories: ,

Your guide to trends and sales potential for prefillable syringe products

What are the commercial prospects for pre-filled syringes and related technologies? Visiongain's report shows you potential revenues and other trends to 2024, discussing data, opportunities and prospects.

Our new study analyses those technologies and their therapeutic applications. You will find projected sales to 2024 at overall world market, submarket, injected drug and national level.

In addition to an overall world revenue forecast for pre-filled syringe products, you will see forecasting of world-level submarkets to 2024:
• Glass pre-filled syringes
• Plastic (polymer) pre-filled syringes
• Pen injectors and Autoinjectors

Also, you receive a world unit sales forecast for those medical injection units. Discover qualitative analyses (SWOT and STEP), company profiles, R&D and commercial developments. Moreover, you will gain 60 figures, 79 tables and three interviews with authorities in the industry.

Prospects for leading countries shown to 2024

Regulatory, demographic and commercial developments worldwide will influence the market, especially fast-rising demand in emerging markets.

Our analyses show you individual revenue forecasts to 2024 for 11 national markets:
• US
• Japan
• Germany,
• France,
• UK,
• Italy
• Spain
• Brazil,
• Russia,
• India
• China

Increasing development and use of biological drugs (biologics) will increase worldwide sales of these drug delivery technologies from 2014 to 2024, our study shows.

What issues decide the future of the industry and market?

Our study lets you assess industry trends and outlooks. You find discussions of many issues and developments, including R&D:
• Cost savings and efficiencies
• Plastic disposable syringes and components
• Glass single-use syringes and related parts
• Syringe technology, needles, materials and compound stability
• Safety and convenience issues for injection devices
• Product differentiation and customisation
• Reimbursement and legislation

Our investigation gives you multi-level business research and analysis with sales forecasts. You see how that industry and market can perform from 2014 to 2024.

You will discover prospects for applications of prefillable syringe technologies

Our report also analyses applications of pre-filled drug delivery technologies – medical products. You will discover world-level revenue forecasting for several drug classes to 2024 including:
• Insulins
• Growth hormones
• Low molecular weight heparins (LMWHs)
• Vaccines
• Biosimilar and follow-on protein products

Also, how will 11 injectable drugs – including Lantus, Humalog, NovoLog, Humira and Enbrel – perform from 2014? You will find the potential revenues for these drugs to 2024.

Market Size and Growth Prospects

What does the future hold? Overall revenues from pre-filled syringes will rise from 2014 to 2024, our report forecasts. Improved drug delivery and new formulations will be vital to pharmaceutical companies, increasing demand for innovative medical injection devices.

In 2012, 2.96 billion of those syringe units sold. Pre-filled syringes form one of the fastest growing markets in healthcare.

Safety, stability, convenience and cost-effectiveness benefit unit sales and revenues. Our analyses predict strong revenue growth to 2024 for those medical devices and their applications in human therapy.

Discover profiles for leading companies

Our work profiles leading companies, assessing their technologies and products. You will see activities and outlooks for developers and producers:
• Becton, Dickinson and Company
• Gerresheimer
• SCHOTT
• Ypsomed
• MGlas (Nipro)
• Unilife
• Nuova Ompi (Stevanato Group)
• Weigao
• Roselabs Bioscience
• SHL Group
• Haselmeier
• Owen Mumford
• Datwyler
• West Pharmaceutical Services

Our work also discusses companies providing syringe filling machines and associated equipment.

How the Pre-Filled Syringes: World Industry and Market Prospects 2014-2024 report helps you

In summary, our report gives you the following knowledge:
• Revenues to 2024 for the overall world market – discover that industry's prospects, finding promising areas for investments and revenues
• Discover forecasted revenue trends of leading applications
• Find projected revenues of 11 leading therapeutic products to 2024
• Market forecasting to 2024 for the US, Japan, leading EU countries (Germany, France, the UK, Italy and Spain), and BRIC countries, India, China, Brazil and Russia
• Assess 14 leading companies, and other players, discovering activities and outlooks
• Competition and opportunities – see what affects the pre-filled syringe market, learning what shapes its future, especially prospects for sustaining and developing business
• Opinions from our survey, seeing interviews with industry authorities.

You will find quantitative and qualitative analyses with independent predictions. You receive information that only our report contains, staying informed on business intelligence.

Gain research and analysis for pre-filled syringes and related drug delivery now

Our study is for everybody needing industry and market analyses for pre-filled syringes and related technologies. You find data, trends and predictions. Please order the Pre-Filled Syringes: World Industry and Market Prospects 2014-2024 report now.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

To view free sample pages of this report please click here

Download sample pages

Complete the form below to download your free sample pages for Pre-Filled Syringes: World Industry and Market Prospects 2014-2024


Download sample pages

Complete the form below to download your free sample pages for Pre-Filled Syringes: World Industry and Market Prospects 2014-2024


Latest Pharma news

Visiongain Publishes Checkpoint Inhibitors for Treating Cancer Market Report 2021-2031

We predict strong revenue growth through to 2031. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

29 July 2021

READ

Visiongain Publishes Direct-to-Patient Market Report 2021-2031

Over the last few years, Direct-to-Patient has gained widespread attention. DTP companies offer their customers, who are patients, in this case, all kinds of services.

21 July 2021

READ

Visiongain Publishes Drug Delivery Technologies Market Report 2021-2031

Rising geriatric population, increasing prevalence of chronic and infectious diseases, escalating investment in drug R&D by biopharmaceutical companies, rising demand for advanced drug delivery technologies for chronic treatment are some of the major factors that drive the growth of the global drug delivery technologies market.

20 July 2021

READ

Visiongain Publishes Pharma Contract Sales Market Report 2021-2031

Pharma services companies are widening their service offerings (either organically or inorganically through M&A) to become full-service providers, simplifying their customers’ operations and gaining the maximum share of their outsourcing budgets, driven by the willingness of pharma to reduce the number of outsourcers they use.

14 July 2021

READ

Categories